Volume 15 Supplement 1
PB.43: Review of the determinants of poor screening uptake at City, Sandwell and Walsall Breast Screening Units and the steps taken to improve attendance
© Khan et al.; licensee BioMed Central Ltd. 2013
Published: 8 November 2013
The aim of National Health Services Breast Screening Programme (NHSBSP) is to reduce morbidity and mortality related to breast cancer. The success of NHSBSP depends upon a high proportion of women attending for their 3-yearly screening mammograms. The national target for screening attendance is 80% and the minimum standard is 70%. For 2010 and 2011, an overall national screening uptake for women aged 50 to 70 was 73.4%. The overall uptake rate for our screening service is recorded as the fifth lowest in achieving minimum uptake targets. The purpose of this review was to analyse the factors associated with poor uptake in some of our screening regions and assess the effectiveness of the methods used to maximise attendance in these regions.
The source of our data collection was west Midlands Cancer Intelligence Unit and NHSBSP database. We analysed the trends in screening uptake from 2007 to 2013.
Social deprivation, population size, ethnicity, availability and access, and education and awareness are some of the most significant factors that affect uptake. Interventions were devised to target these factors. The initiatives used were simple such as patient letters, promotional posters and multi-lingual leaflets, DNA flyers, telephonic reminders and most importantly collaborative work with GP surgeries. The results were encouraging and we managed to increase the prevalent uptake by 7.87% in our lowest uptake region.
- NHS Breast Screening Programme Annual Review. 2012, ISBN 978-1-84463-093-6Google Scholar
- NHS Cancer Screening Programme. 2005, ISBN 1 84463 024 2 | ArchivedGoogle Scholar
- Maximizing Screening Attendance Reference Guide. 2009, Dr Christiane Zelenyanszki Joint Screening Lead. NWLCN (North West London Cancer Network) December 2009Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.